SILENCE THERAPEUTICS PLC-ADR (SLN) Stock Income Statement
NASDAQ:SLN - Nasdaq - US82686Q1013 - ADR - Currency: USD
| 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | 2016 (2016-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.48M | 244.00K | 0.00 | 16.00K | 770.00K | |||
| Cost Of Goods | 3.76M | N/A | N/A | N/A | N/A | |||
| Gross Profit | 1.72M | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 37.56M | 22.98M | 20.57M | 14.41M | 12.68M | |||
| Research and Development | 20.21M | 13.34M | 9.74M | 7.94M | 8.71M | |||
| Selling, General, and Administrative Expenses | 13.98M | 9.64M | 10.83M | 6.46M | 3.96M | |||
| Operating Income | -35.85M | -22.73M | -20.57M | -14.39M | -11.91M | |||
| Interest Income/Expense | -194.00K | -136.00K | 45.00K | 10.66M | 2.11M | |||
| Other Income/Expense | N/A | N/A | N/A | -49.00K | -564.00K | |||
| Income Before Taxes | -36.04M | -22.87M | -20.53M | -3.77M | -10.36M | |||
| Income Tax | -3.49M | -3.29M | -2.12M | -2.16M | -1.92M | |||
| Net Income | -32.55M | -19.58M | -18.41M | -1.62M | -8.44M | |||
| EBITDA | -35.35M | -22.25M | -20.17M | -13.96M | -11.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.40 | -0.26 | -0.26 | -0.02 | -0.12 | |||
| Non GAAP EPS | -0.40 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 31.34% | N/A | N/A | N/A | N/A | |||
| Profit Margin | -594.03% | -8025.41% | N/A | -10112.50% | -1096.10% | |||
| Operating Profit Margin | -654.26% | -9317.21% | N/A | -89943.75% | -1546.23% | |||
All data in GBP